Logo image of THOR

Synthorx INC (THOR) Stock Price, Forecast & Analysis

USA - NASDAQ:THOR -

67.99
0 (0%)
Last: 1/22/2020, 9:33:30 PM

THOR Key Statistics, Chart & Performance

Key Statistics
Market Cap2.20B
Revenue(TTM)N/A
Net Income(TTM)-63.60M
Shares32.34M
Float157.91K
52 Week High71.9
52 Week Low11.05
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-2.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


THOR short term performance overview.The bars show the price performance of THOR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200 300 400

THOR long term performance overview.The bars show the price performance of THOR in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300

The current stock price of THOR is 67.99 null. In the past month the price decreased by -0.04%. In the past year, price increased by 386.69%.

Synthorx INC / THOR Daily stock chart

THOR Latest News, Press Relases and Analysis

4 years ago - By: The Motley Fool - Mentions: WGO
News Image
4 years ago - By: The Motley Fool - Mentions: WGO
News Image
5 years ago - By: Benzinga - Mentions: WGO CWH LCII
News Image
6 years ago - By: Marketwatch
News Image
6 years ago - By: Seeking Alpha - Mentions: SNY
News Image
6 years ago - By: Halper Sadeh LLP - Mentions: INST LOGM
News Image
6 years ago - By: Halper Sadeh LLP - Mentions: HABT INST
News Image

About THOR

Company Profile

Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.

Company Info

Synthorx INC

11099 North Torrey Pines Road Suite 190

La Jolla CA 92037

CEO: Laura Shawver

Phone: 858-750-4700

Synthorx INC / THOR FAQ

Can you describe the business of Synthorx INC?

Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.


What is the current price of THOR stock?

The current stock price of THOR is 67.99 null.


What is the dividend status of Synthorx INC?

THOR does not pay a dividend.


How is the ChartMill rating for Synthorx INC?

THOR has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


THOR Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to THOR. When comparing the yearly performance of all stocks, THOR is one of the better performing stocks in the market, outperforming 99.83% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

THOR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to THOR. While THOR has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

THOR Financial Highlights

Over the last trailing twelve months THOR reported a non-GAAP Earnings per Share(EPS) of -2.0100000000000002. The EPS decreased by -172.24% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -38.86%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-172.24%
Revenue 1Y (TTM)N/A

THOR Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y76.63%
Revenue Next YearN/A

THOR Ownership

Ownership
Inst Owners66.12%
Ins Owners1.99%
Short Float %N/A
Short RatioN/A